Zinforo
by Pfizer
Active ingredient: Ceftaroline fosamil
Packs
- Inf · 600 mg · 10 Vial (110515)
- Inf · 600 mg · Vial (110515)
About Ceftaroline Fosamil
Cephalosporin
Uses
Complicated SSTI, Community-acquired pneumonia.
How to take it
Adults: By IV infusion: 600mg over 60 minutes every 12 hours. Continue for 5-7 days in pneumonia and for 5-14 days in SSTI. Geriatrics: Same as adults. Children: Recommended durations of treatment are 5-14 days for cSSTI and 5-7 days for CAP. 12-18 yrs: Body wt: =33 kg: 600 mg over 60 mins every 12 hrs. Body wt <33kg: 12 mg/kg to a max of 400 mg over 60 mins every 8 hrs. =2yrs-<12 yrs: 12 mg/kg to a max of 400 mg over 60 mins every 8 hrs. Infants =2 mths-<2yrs: 8 mg/kg over 60 mins every 8 hrs. Neonates from birth-<2 mths: 6 mg/kg over 60 mins every 8 hrs. Administered by IV infusion over 1 hour. Reconstitution: The contents of ceftaroline fosamil vial should be reconstituted with 20 mL of…
Side effects
Positive coombs test, rash, pruritus, GI upset, raised LFTs, fever, headache, dizziness, phlebitis, infusion site reactions, hypersensitivity reactions, pseudomembranous colitis, haemolytic anaemia.
Pregnancy and breastfeeding
Pregnancy: Contraindicated in pregnancy. Lactation: Contraindicated or not recommended. Contraindications: Hypersensitivity to the cephalosporin class of antibacterials. Immediate and severe hypersensitivity (e.g. anaphylactic reaction) to any other type of beta-lactam antibacterial agent (e.g. penicillins or carbapenems). Precautions: Non-severe hypersensitivity to other B-lactams, renal impairment (CrCl < 50ml/mins), history of seizures, pork risk class V and/or pneumonia requiring ventilation at presentation, pneumonia due to MRSA or requiring intensive care, immunocompromised, severe sepsis or septic shock, pneumonia, severe underlying lung disease.
Full information on Ceftaroline Fosamil →
Need Zinforo? Ask us to source Zinforo and our pharmacist will call you back.
Other brands with the same ingredients
More from Pfizer
Compiled by Healify Pharmacy from published drug references. How we compile it →
Always consult a pharmacist or doctor.